Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Abstract

A new interactive web-based resource, called 'Cancer e-Atlas', has been developed to improve access to cancer statistics across England. It aims to provide health care professionals, commissioners, health service managers and the public with information on incidence, mortality and survival for the common types of cancers in men and women. Data available in Excel format. Using data from English cancer registries and the Office for National Statistics, cancer statistics (incidence and mortality) are shown for Local Authorities and Cancer Networks. Survival statistics are also shown but at Cancer Network level only.

Main Topics/Subject Category
Incidence, mortality and survival
Variables

Incidence and mortality of all malignant neoplasms and cancers by age

Keywords
Malignant neoplasms, bladder cancer, brain, breast, cervix, colorectal cancer, kidney, leukemia, lung cancer, melanoma, non-hodgkins lymphoma, oesophagus, ovary, pancreas, prostate, stomach cancer, uterus
Identifier Variables
LA, cancer network, GOR
Area of Health System
Public health
Disease Area
Cancer
Data Available
Socio-economic, Demographic
Data collecting organization (s)
National Cancer Intelligence Network
Data Type
Administrative
National/Regional
National
Coverage (date of field work)
1993, 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004
Unit of Analysis
Individual
Sample

Annual count of all cancer incidence. Ranges from ~ 2000 - 10342

Availability
National Cancer Intelligence Network
Conditions of Access
Free access
Link
http://www.ncin.org.uk/analysis/eatlas.shtml
Contact
Tel: 02070618137, enquiries@ncin.org.uk
Publications
Rachet B, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009; 10: 351–69